Skip to main content
Livermore
Livermore
ZHEN

KBC Group NV

SEC CIK
0001411133
Latest filing
Aug 5, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by KBC Group NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
3,773
Value
$308.0K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of ARWR by KBC Group NV, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,773$308.0K<0.1%00.0%UnchangedHolders
Q1 20263,773$237.0K<0.1%−976−20.6%ReducedHolders
Q4 20254,749$315.0K<0.1%00.0%UnchangedHolders
Q3 20254,749$164.0K<0.1%00.0%UnchangedHolders
Q2 20254,749$75.0K<0.1%−2,607−35.4%ReducedHolders
Q1 20257,356$94.0K<0.1%+2,132+40.8%AddedHolders
Q4 20245,224$98.0K<0.1%+1,644+45.9%AddedHolders
Q3 20243,580$69.0K<0.1%00.0%UnchangedHolders
Q2 20243,580$93.0K<0.1%+835+30.4%AddedHolders
Q1 20242,745$79.0K<0.1%+470+20.7%AddedHolders
Q4 20232,275$70.0K<0.1%00.0%UnchangedHolders
Q3 20232,275$61.0K<0.1%+1,370+151.4%AddedHolders
Q2 2023905$32.0K<0.1%00.0%UnchangedHolders
Q1 2023905$23.0K<0.1%+287+46.4%AddedHolders
Q4 2022618$25.0K<0.1%+618NewHolders
Q2 20220$00.0%−2,192−100.0%Sold outHolders
Q1 20222,192$101.0K<0.1%+2,192NewHolders
Q4 20210$00.0%−2,655−100.0%Sold outHolders
Q3 20212,655$166.0K<0.1%00.0%UnchangedHolders
Q2 20212,655$220.0K<0.1%00.0%UnchangedHolders
Q1 20212,655$176.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.